Users of Abbott’s CGM device can now view data and gain additional insights through Glooko’s diabetes management platform.

Glooko announced today that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U ...

AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.

The Joseph P. Addabbo Family Health Center (JPAFHC) in Southeast Queens is making significant strides in diabetes care in New ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...

Devices such as smartwatches, biosensors, and implantable monitors are now routinely used to track blood pressure, glucose ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Insulet Corporation’s RADIANT study shows glycaemic improvements with Omnipod 5 automated insulin delivery system: Action, Massachusetts Friday, March 21, 2025, 18:00 Hrs [IST] ...

Abbott is already a big player in the wearable glucose-monitoring sector ... of a small patch-like device similar to Abbott's FreeStyle Libre 3 device (pictured above), and a prototype version ...

Corporation shared new Omnipod 5 clinical data from its RADIANT study. Results from this multinational randomized controlled ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM ... the G7 and Libre 3 range. Analysts at William Blair said that with two devices ...